<DOC>
	<DOC>NCT01640847</DOC>
	<brief_summary>This study will evaluate treatment with High Intensity Focused Ultrasound (HIFU)in combination with ThermoDox (liposomal doxorubicin) is safe and effective in reducing pain for patients with painful bone metastases.</brief_summary>
	<brief_title>MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms, Second Primary</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<mesh_term>Pain</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>Histological confirmation of breast carcinoma, nonsmall cell lung cancer, small cell lung cancer, or adenocarcinoma of the prostate Bone metastases index lesion in the ribs, clavicle, scapula, upper extremities, pelvis, or posterior aspects of the lumbar vertebra L3L5 or sacral S1S5. Patients will have failed at least one prior attempt or will not be eligible for external beam radiation therapy (EBRT) Greater than 450 mg/m2 of prior free doxorubicin and/or nonheat activated liposomal doxorubicin LVEF &lt; 50% Significant Cardiac History Brain Metastases Contraindication for MR imaging (as incompatible implanted metallic device, weight &gt;250 lbs etc) or known intolerance or allergy to MRI contrast agents.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Painful bone metastases</keyword>
	<keyword>Bone Cancer</keyword>
	<keyword>Bone Cancer Pain</keyword>
	<keyword>Patients with</keyword>
</DOC>